Sheel Biotech Limited has built its presence in biotechnology, floriculture, greenhouses, and organic projects, creating a diverse portfolio that caters to both government and private sectors. The company’s core business revolves around producing high-quality planting material through tissue culture and hydroponics, while also offering greenhouse construction, landscaping, and organic certification services. Backed by recognised research facilities and quality certifications, Sheel Biotech has established itself as a reliable player in the agricultural and biotechnology space. Its commitment to farmer training and Farmer Producer Organization (FPO) management further strengthens its position in the market.
To apply for the Sheel Biotech IPO, investors can participate through their registered stockbroker or online trading platforms offering IPO application facilities. Applications can be made using the ASBA (Application Supported by Blocked Amount) process via net banking or UPI-linked accounts. By selecting Sheel Biotech IPO from the available issues, entering the required details, and confirming the bid, investors can complete the application process securely and efficiently.
For more details, visit the Sheel Biotech IPO page.
Sheel Biotech IPO Details and Objectives
Details
| Information
|
IPO Date
| September 30, 2025 to October 3, 2025
|
Issue Size
| 54,00,000 shares
(aggregating up to ₹34.02 Cr)
|
Price Band
| ₹59 to ₹63 per share
|
Lot Size
| 2000 shares
|
Listing At
| SME NSE
|
Purpose of the IPO
Capital Expenditure Requirement
Working Capital Expenditure Requirement
General Corporate Purposes
Timeline of Sheel Biotech IPO
Event
| Date
|
---|
IPO Open Date
| Tue, Sep 30, 2025
|
IPO Close Date
| Fri, Oct 3, 2025
|
Tentative Allotment
| Mon, Oct 6, 2025
|
Initiation of Refunds
| Tue, Oct 7, 2025
|
Credit of Shares to Demat
| Tue, Oct 7, 2025
|
Tentative Listing Date
| Wed, Oct 8, 2025
|
Cut-off time for UPI mandate confirmation
| 5 PM on Fri, Oct 3, 2025
|
Pricing & Lot Size of Sheel Biotech IPO
Price Band for the IPO
Minimum Lot Size and Application Details
Application
| Lots
| Shares
| Amount
|
Individual investors (Retail) (Min)
| 2
| 4,000
| ₹2,52,000
|
Individual investors (Retail) (Max)
| 2
| 4,000
| ₹2,52,000
|
S-HNI (Min)
| 3
| 6,000
| ₹3,78,000
|
S-HNI (Max)
| 7
| 14,000
| ₹8,82,000
|
B-HNI (Min)
| 8
| 16,000
| ₹10,08,000
|
Sheel Biotech IPO Application Process
The Sheel Biotech IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Sheel Biotech IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 2000 shares) within the price band of ₹59 to ₹63 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹93.08 crore in FY24 to ₹105.98 crore as of May 2024.
Total income: Reached ₹3.99 crore in FY24.
Profit After Tax (PAT): Stood at ₹0.48crore for May 2024.
Net Worth: Recorded at ₹73.21 crore in FY24.
Reserves and Surplus: Recorded at ₹69.07 crore (May 2024), growing steadily over the years.
Total Borrowing: Stood at ₹25.22 crore in May 2024.
Recent Performance and Growth Prospects
The company has shown consistent growth in its asset base, reflecting financial stability and expansion of operations.
Income generation has remained steady, highlighting the ability to maintain a reliable revenue stream.
Profitability has been sustained, indicating effective management of resources and expenses.
The company’s net worth demonstrates a strong financial foundation and shareholder value.
Reserves and surplus have continued to build over time, showcasing long-term financial resilience.
Borrowings remain at a manageable level, suggesting balanced use of debt for growth while maintaining fiscal discipline.
Investment Risks and Opportunities
Potential Risks of Investing in the IPO
The company operates in agriculture and biotechnology, sectors that are often influenced by environmental factors, regulatory changes, and fluctuations in demand.
Dependence on government projects and farmer adoption of modern practices may expose the business to policy shifts and market uncertainties.
Opportunities and Growth Potential
With expertise in biotechnology, floriculture, greenhouses, and organic farming, the company is positioned to benefit from rising demand for sustainable and innovative agricultural solutions.
Recognised research facilities, quality certifications, and farmer training initiatives provide a foundation for long-term growth and stronger market positioning.
Key Performance Indicator (KPI)
KPI
| Values
|
ROE
| 13.59%
|
ROCE
| 16.34%
|
Debt/Equity
| 0.32
|
RoNW
| 13.59%
|
EBITDA Margin
| 14.71%
|
Price to Book Value
| 1.26
|
Sheel Biotech IPO Registrar & Lead Managers
Registrar
| Lead Manager(s)
|
---|
Skyline Financial Services Pvt.Ltd.
| Narnolia Financial Services Ltd.
|
Company Address of Sheel Biotech Ltd
Sheel Biotech Ltd. 8 Balaji Estates 2nd Floor, Block-C, Guru Ravidas Marg Kalkaji South Delhi, New Delhi, 110019
Phone: +91 88511 - 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/
Conclusion
Sheel Biotech Limited operates across biotechnology, floriculture, greenhouses, and organic farming, supported by recognised research facilities and industry certifications. Its business model includes production of planting material, greenhouse development, landscaping, and farmer training initiatives, allowing it to cater to both private and government projects.
The IPO aims to raise funds for capital expenditure, working capital needs, and general corporate purposes. Investors can participate in the issue through the ASBA process or UPI-enabled applications within the designated timeline.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Sheel Biotech IPO allotment status.